SCHEMBL1674013

SCHEMBL1674013

CC(=O)CCc1ccc(CO)c(O)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.47
MAPT P10636 3/20 0.47
LMNA P02545 2/20 0.47
NPC1 O15118 1/20 0.47
TP53 P04637 1/20 0.47
CYP1A2 P05177 1/20 0.47
CYP3A4 P08684 1/20 0.47
MAOA P21397 1/20 0.47
SLC6A2 P23975 1/20 0.47
RAB9A P51151 1/20 0.47
SLC6A3 Q01959 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
IAPP P10997 4/20 0.47
ALDH1A1 P00352 3/20 0.47
HPGD P15428 1/20 0.42
PTGS1 P23219 1/20 0.42
BLM P54132 1/20 0.42
HIF1A Q16665 1/20 0.42
HSD17B10 Q99714 1/20 0.42
PKM P14618 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3415131 0.86 PKM (0.59) KDM4EMAPTLMNANPC1TP53
SCHEMBL1674014 0.86 LMNA (0.50) KDM4EMAPTLMNANPC1TP53
SCHEMBL20045032 0.84 POLB (0.49) KDM4EMAPTLMNACYP1A2IAPP
SCHEMBL1260798 0.82 IAPP (0.68) KDM4EMAPTLMNANPC1TP53
SCHEMBL14756898 0.79 KDM4E (0.71) KDM4EMAPTLMNASMN1; SMN2ALDH1A1
SCHEMBL27720465 0.79 IAPP (0.50) KDM4EMAPTLMNANPC1TP53
SCHEMBL16750370 0.78 NPC1 (0.46) KDM4EMAPTLMNANPC1TP53
SCHEMBL14740881 0.77 KDM4E (0.55) KDM4EMAPTLMNANPC1TP53
SCHEMBL1405219 0.77 KDM4E (0.49) KDM4EMAPTLMNANPC1TP53
SCHEMBL9973601 0.77 ALDH1A1 (0.47) KDM4EMAPTLMNANPC1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9381143-B2 Use of substituted methoxyalkoxyphenylalkyl derivatives as preservative, preserving method, compounds and composition L'OREAL (FR) 2016-07-05 US disclosed
US-20130230473-A1 USE OF SUBSTITUTED METHOXYALKOXYPHENYLALKYL DERIVATIVES AS PRESERVATIVE, PRESERVING METHOD, COMPOUNDS AND COMPOSITION L'OREAL (FR) 2013-09-05 US disclosed
WO-2012045809-A1 USE OF SUBSTITUTED METHOXYALKOXYPHENYLALKYL DERIVATIVES AS PRESERVATIVE, PRESERVING METHOD, COMPOUNDS AND COMPOSITION L'OREAL (FR) 2012-04-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130230473-A1 USE OF SUBSTITUTED METHOXYALKOXYPHENYLALKYL DERIVATIVES AS PRESERVATIVE, PRESERVING METHOD, COMPOUNDS AND COMPOSITION H1-0, H1-3, C9 KDM4E 224/4885MAPT 3611/4885LMNA 125/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.